Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma

Tumors of the upper gastrointestinal tract are increasing in incidence; yet, approaches to the treatment of advanced gastric and/or gastroesophageal junction cancer vary widely, with no internationally agreed first‐line regimens. Recent clinical trials have shown that second‐line treatment is now po...

Descripción completa

Detalles Bibliográficos
Autores principales: Pericay, Carles, Rivera, Fernando, Gomez‐Martin, Carlos, Nuñez, Inmaculada, Cassinello, Alejo, Imedio, Esteban Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224844/
https://www.ncbi.nlm.nih.gov/pubmed/27774774
http://dx.doi.org/10.1002/cam4.941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224844/
https://www.ncbi.nlm.nih.gov/pubmed/27774774
http://dx.doi.org/10.1002/cam4.941

Ejemplares similares